Jane Vickery
Impact in
- Pharmacology top 2%
- Cannabis and Cannabinoid Research
-
- Multiple Sclerosis Research Studies
Papers in
-
- Multiple Sclerosis Research Studies 8
- Surgery 7
- Healthcare Technology and Patient Monitoring 2
- Co-authors
- John Zajicek (10 shared papers)Andrew Nunn (3 shared papers)D. Wright (2 shared papers)Alan J. Thompson (2 shared papers)Patrick J. Fox (2 shared papers)Jeremy Hobart (3 shared papers)Andy Barton (8 shared papers)Siobhan Creanor (11 shared papers)
- Journals
- BMJ Open (5 papers)Health Technology Assessment (2 papers)The Lancet (2 papers)Physiotherapy (2 papers)BMC Neurology (1 paper)
- Partner nations
- United KingdomUnited StatesTaiwan
In The Last Decade
Jane Vickery
29 papers receiving 965 citations
Jane Vickery's Hit Papers
Peers
Comparison fields: 5 of 98
- Pharmacology 495
- Pathology and Forensic Medicine 280
- Toxicology 53
- Neurology 172
- Cellular and Molecular Neuroscience 174
Countries citing papers authored by Jane Vickery
This map shows the geographic impact of Jane Vickery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Vickery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Vickery more than expected).
Fields of papers citing papers by Jane Vickery
This network shows the impact of papers produced by Jane Vickery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Vickery. The network helps show where Jane Vickery may publish in the future.
Co-authors
The 25 scholars most cited alongside Jane Vickery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial Hit paper breakdown → | 2003 | 557 |
| 2 | 2015 | 110 | |
| 3 | 2013 | 95 | |
| 4 | 2015 | 50 | |
| 5 | 2010 | 44 | |
| 6 | 2019 | 25 | |
| 7 | 2018 | 17 | |
| 8 | 1980 | 15 | |
| 9 | 2019 | 13 | |
| 10 | 2021 | 12 | |
| 11 | 2017 | 11 | |
| 12 | 2021 | 10 | |
| 13 | 2017 | 9 | |
| 14 | 2014 | 9 | |
| 15 | 2016 | 9 | |
| 16 | 2013 | 7 | |
| 17 | 2022 | 6 | |
| 18 | 2014 | 6 | |
| 19 | 1979 | 3 | |
| 20 | 1971 | 3 |
About Jane Vickery
Jane Vickery is a scholar working on Pathology and Forensic Medicine, Surgery, Psychiatry and Mental health, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 30 papers that have together received 1.0k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (8 papers), Cerebral Palsy and Movement Disorders (5 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Stroke Rehabilitation and Recovery (3 papers), Non-Invasive Vital Sign Monitoring (3 papers), Cardiac Arrhythmias and Treatments (2 papers), Healthcare Technology and Patient Monitoring (2 papers) and Cannabis and Cannabinoid Research (2 papers). The work is most often cited by research in Pharmacology (495 citations), Pathology and Forensic Medicine (280 citations), Toxicology (53 citations), Neurology (172 citations) and Cellular and Molecular Neuroscience (174 citations). Jane Vickery has collaborated with scholars based in United Kingdom, United States and Taiwan. Frequent co-authors include John Zajicek, Andrew Nunn, D. Wright, Alan J. Thompson, Patrick J. Fox, Jeremy Hobart, Andy Barton, Siobhan Creanor, Susan Ball and Paul Ewings. Their work appears in journals such as BMJ Open, Health Technology Assessment, The Lancet, Physiotherapy and BMC Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.